---

Studies on serum soluble endoglin: An indicator for preeclampsia

---

Original Article

Author Details : Archana A*, Brindha G, Ursula Sampson

Volume : 5, Issue : 4, Year : 2018

Article Page : 599-603

https://doi.org/10.18231/2394-6377.2018.0127

Suggest article by email

Get Permission

---

Abstract

Introduction: To study the concentration of serum soluble endoglin during second trimester pregnancy and monitor for the development of preeclampsia.
Materials and Methods: Seventy-five healthy singleton pregnant women in second trimester was evaluated in this study. ELISA technique was used for measuring the concentration of Serum soluble endoglin. Patients with increased level of serum endoglin were monitored for signs and symptoms of preeclampsia.
Result: Thirty five pregnant women developed preeclampsia among 75 pregnant women. The mean value for sENG in cases was 8.7 ± 1.4 and control 5.9 ± 0.6. The normal value of serum sENG varies from 2.54 to 7.06 ng/ml. Hence, it is higher than the normal limit in cases.
Conclusions: The concentration of sENG was studied and women were monitored for development of preeclampsia. The present study showed that women with increased serum soluble endoglin levels developed preeclampsia later. Hence, it is suggested that soluble endoglin will be useful in predicting pre eclampsia.

Keywords: Endoglin, Preeclampsia, ELISA, sENG.

How to cite : Archana A, Brindha G, Sampson U, Studies on serum soluble endoglin: An indicator for preeclampsia. Int J Clin Biochem Res 2018;5(4):599-603

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.